CR Intrinsic Investors’s Merck MRK Stock Holding History

CR Intrinsic Investors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-157,200	Closed	-$7.14M	–	332
2013 Q3	$7.14M	Buy	+157,200	New	+$7.18M	0.22%	156

Other funds holding MRK

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CR Intrinsic Investors's MRK Position: Q2 2014 in Review

CR Intrinsic Investors sold out of Merck (MRK) in Q2 2014, closing a stake of 209,600 shares — an estimated $11.4M sold.

CR Intrinsic Investors first reported a position in MRK in Q1 2014 and held it in 1 quarter. The position peaked at $11.4M in Q1 2014. 1,621 funds tracked by Wall St. Rank hold MRK as of Q2 2014.

CR Intrinsic Investors reported no remaining Merck position as of Q2 2014 after selling out during the quarter.
CR Intrinsic Investors sold 209,600 Merck shares in Q2 2014, an estimated $11.4M.
CR Intrinsic Investors first reported a position in Merck in Q1 2014 and held it in 1 quarter.
CR Intrinsic Investors's Merck position peaked at $11.4M in Q1 2014.
1,621 funds tracked by Wall St. Rank held Merck as of Q2 2014.

Based on CR Intrinsic Investors's 13F filing for Q2 2014.